| abstract |
An oral pharmaceutical composition of the present invention, which contains a compound having CCR5 antagonistic action dissolved or dispersed in an amphiphilic substance-containing carrier, shows less dispersion in the blood concentration of a compound having CCR5 antagonistic action or a salt thereof, shows extremely fine oral absorption, and makes a preparation for oral administration useful for the prophylaxis or treatment of various HIV infectious diseases in human. |